A BILL 
To amend the Federal Food, Drug, and Cosmetic Act with 
respect to compounding pharmacies, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Preserving Patient Ac-
4
cess to Compounded Medications Act of 2019’’. 
5
SEC. 2. OFFICE-USE COMPOUNDING WHEN AUTHORIZED BY 
6
STATE LAW. 
7
Section 503A(a) of the Federal Food, Drug, and Cos-
8
metic Act (21 U.S.C. 353a(a)) is amended— 
9
04:42 Apr 11, 2019
H1959
2 
•HR 1959 IH
(1) in the matter preceding paragraph (1), by 
1
inserting ‘‘or drug order for administration to a pa-
2
tient in an office or clinical setting’’ after ‘‘is nec-
3
essary for the identified patient’’; 
4
(2) in paragraph (1), by striking ‘‘or’’ at the 
5
end; 
6
(3) in paragraph (2), by striking the period at 
7
the end and inserting ‘‘; or’’; and 
8
(4) by adding at the end the following new 
9
paragraph: 
10
‘‘(3) is by a licensed pharmacist or licensed 
11
physician pursuant to a valid prescription order or 
12
drug order and the compounded drug is distributed 
13
or dispensed to a licensed prescriber in accordance 
14
with State law, for administration to a patient in an 
15
office or clinical setting.’’. 
16
SEC. 3. UNITED STATES PHARMACOPOEIA OR NATIONAL 
17
FORMULARY MONOGRAPH REQUIREMENT. 
18
Section 503A(b)(1)(A) of the Federal Food, Drug, 
19
and Cosmetic Act (21 U.S.C. 353A(b)(1)(A)) is amend-
20
ed— 
21
(1) in the matter preceding subclause (i), by in-
22
serting ‘‘, or dietary supplements’’ after ‘‘Regula-
23
tions’’; and 
24
(2) in clause (i)— 
25
04:42 Apr 11, 2019
H1959
3 
•HR 1959 IH
(A) by amending subclause (I) to read as 
1
follows: 
2
‘‘(I) comply with the monograph 
3
standards in any section of the United 
4
States Pharmacopoeia or National 
5
Formulary, including drug substance 
6
or dietary supplement monograph, if a 
7
monograph exists.’’; and 
8
(B) by amending subclause (III) to read as 
9
follows: 
10
‘‘(III) if such monograph does 
11
not exist and the drug substance or 
12
dietary supplement is not a compo-
13
nent of a drug approved by the Sec-
14
retary, but appears on a list developed 
15
by the Secretary through regulations 
16
issued by the Secretary under sub-
17
section (c) of this section;’’. 
18
SEC. 4. DEFINITIONS. 
19
Subsection (e) of section 503A of the Federal Food, 
20
Drug, and Cosmetic Act (21 U.S.C. 353a) is amended to 
21
read as follows: 
22
‘‘(e) DEFINITIONS.—In this section: 
23
‘‘(1) COMPOUNDING.—The term ‘compounding’ 
24
does not include mixing, reconstituting, or other 
25
04:42 Apr 11, 2019
H1959
4 
•HR 1959 IH
such acts that are performed in accordance with di-
1
rections contained in approved labeling provided by 
2
the product’s manufacturer and other manufacturer 
3
directions consistent with that labeling. 
4
‘‘(2) 
DISTRIBUTE
OR
DISTRIBUTION.—The 
5
terms ‘distribute’ or ‘distribution’ do not include the 
6
act of dispensing of a compounded drug product in 
7
accordance with this section. 
8
‘‘(3) DISPENSE.—The term ‘dispense’ means 
9
for a drug product compounded in accordance with 
10
this section, the act of the drug product leaving the 
11
facility in which it was compounded for delivery to 
12
a patient, patient’s agent, or health care facility (in-
13
cluding a hospital, physician’s office, or other health 
14
care setting) pursuant to a valid prescription order 
15
for an identified patient.’’. 
16
SEC. 5. APPLICABILITY OF RECORDS EXEMPTION FOR 
17
COMPOUNDING PHARMACIES. 
18
(a) IN GENERAL.—Section 704(a)(2)(A) of the Fed-
19
eral Food, Drug, and Cosmetic Act (21 U.S.C. 
20
374(a)(2)(A)) is amended to read as follows: 
21
‘‘(A) pharmacies which maintain establish-
22
ments in conformance with any applicable local 
23
laws regulating the practice of pharmacy and 
24
medicine and, for compounding pharmacies, the 
25
04:42 Apr 11, 2019
H1959
5 
•HR 1959 IH
provisions of section 503A, and which are regu-
1
larly engaged in dispensing or distributing pre-
2
scription drugs or devices, upon prescriptions or 
3
drug orders of practitioners licensed to admin-
4
ister such drugs or devices to patients under 
5
the care of such practitioners in the course of 
6
their professional practice, and which do not, ei-
7
ther through a subsidiary or otherwise, manu-
8
facture, prepare, propagate, compound, or proc-
9
ess drugs or devices for sale other than in the 
10
regular course of their business;’’. 
11
(b) REGISTRATION EXEMPTION.—Section 510(g)(1) 
12
of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
13
360(g)(1)) is amended to read as follows: 
14
‘‘(1) pharmacies which maintain establishments 
15
in conformance with any applicable local laws regu-
16
lating the practice of pharmacy and medicine and, 
17
for compounding pharmacies, the provisions of sec-
18
tion 503A, and which are regularly engaged in dis-
19
pensing or distributing prescription drugs or devices, 
20
upon prescriptions or drug orders of practitioners li-
21
censed to administer such drugs or devices to pa-
22
tients under the care of such practitioners in the 
23
course of their professional practice, and which do 
24
not manufacture, prepare, propagate, compound, or 
25
04:42 Apr 11, 2019
H1959
6 
•HR 1959 IH
process drugs or devices for sale other than in the 
1
regular course of their business;’’. 
2
SEC. 6. REGULATIONS. 
3
(a) RULES IMPLEMENTING NEW REQUIREMENTS.— 
4
Not later than 90 days after the date of enactment of this 
5
Act, the Secretary of Health and Human Services shall 
6
promulgate rules on the record to carry out the amend-
7
ments made by this Act, in accordance with chapter 5 of 
8
title 5, United States Code. 
9
(b) OTHER RULES.—The Secretary of Health and 
10
Human Services shall promulgate rules on the record to 
11
carry out any of the provisions of section 503A of the Fed-
12
eral Food, Drug, and Cosmetic Act (21 U.S.C. 353a) 
13
other than those amended by this Act, in accordance with 
14
chapter 5 of title 5, United States Code. 
15
Æ 
04:42 Apr 11, 2019
H1959
